Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort
about
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort
description
scientific article published on 14 April 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2016
@uk
name
Effectiveness and safety of fi ...... the ETNA observational cohort
@en
Effectiveness and safety of fi ...... the ETNA observational cohort
@nl
type
label
Effectiveness and safety of fi ...... the ETNA observational cohort
@en
Effectiveness and safety of fi ...... the ETNA observational cohort
@nl
prefLabel
Effectiveness and safety of fi ...... the ETNA observational cohort
@en
Effectiveness and safety of fi ...... the ETNA observational cohort
@nl
P2093
P50
P1476
Effectiveness and safety of fi ...... the ETNA observational cohort
@en
P2093
Angela Grelaud
Annie Fourrier-Réglat
Denis Smith
Jérémy Jové
Magali Rouyer
Philip Robinson
Rosine Guimbaud
Yves Becouarn
P304
P356
10.1016/J.JGO.2016.03.004
P577
2016-04-14T00:00:00Z